Meptazinol

This classification denotes an opioid receptor agonist with the molecular formula C15H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 18Y7S5JKZD, chemically known as phenol, 3-(3-ethylhexahydro-1-methyl-1h-azepin-3-yl)- but generally known as meptazinol, which bears US NIH Compound Identifier 41049. European Medicines Agency schedules Meptazinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08761MIG. The term MEPTAZINOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). World Health Organization schedules meptazinol in its Anatomical Therapeutic Chemical (ATC) Classification. MEPTAZINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule meptazinol under HS 29339930 and SITC 51577. As of Q4 2014, MEPTAZINOL remains the US FDA Preferred Term for this commodity. Meptazinol bears US NLM identifiers UMLS ID C0025387 and NCI Concept Code C87360. SMILES: OC1CC(C2(CCCCN(C2)C)CC)CCC1.